In This Article:
Following the announcement of preliminary fourth-quarter and full-year 2024 results, including a predicted 13% to 16% increase in global da Vinci operations for 2025, Intuitive Surgical (ISRG, Financials) rose 7.9% to $581.34 on Wednesday as of 2:16 p.m. ET.
Rising 25% from $1.93 billion last year, preliminary fourth-quarter sales came at $2.41 billion. Comparing $7.12 billion in 2023 to $8.35 billion, full-year income increased 17%. With 493 systems installed in the fourth quarterincluding 174 da Vinci 5 systemsthe business also saw strong increase in da Vinci surgical system deployments. From 415 positions in the fourth quarter of 2023, this is a 19%. rise. Placed for the whole year came at 1,526 systems, an 11% increase from 1,370 in 2023.
With 2.68 million procedures carried out in 2024, up from 2.29 million in 2023, worldwide da Vinci operations expanded 18% in the fourth quarter and 17% for the year. A 19% increase in U.S. general operations and a 23% rise in cancer-related procedures performed outside the United States helped to explain this increase.
Revenue from instruments and accessories jumped 23% in the fourth quarter to $1.41 billion. This category increased by 19% during the whole year, coming to $5.08 billion. While full-year systems sales rose 17% to $1.97 billion, systems revenue for the quarter climbed 36% to $655 million.
Emphasizing client acceptance of the da Vinci 5, Ion, and SP platforms, CEO Gary Guthart underlined once again the company's emphasis on improving patient outcomes. The findings are still preliminary and subject to last audit corrections.
This article first appeared on GuruFocus.